Phytoadaptogen correction of clinical and immunobiological parameters in patients with benign prostatic hyperplasia.
Correction of hormonal, immune, interferon, and antioxidant status and genetic abnormalities with a complex phytoadaptogen leads to positive clinical effects in elderly patients with benign prostatic hyperplasia.
Bocharova
O A
OA
N. N. Blokhin Cancer Research Center, Russian Academy of Medical Sciences, Moscow.
Matveev
V B
VB
Karpova
R V
RV
Aksyonov
A A
AA
Gorozhanskaya
E G
EG
Chebotaryov
F N
FN
Katosova
L D
LD
Platonova
V I
VI
Bochkov
N P
NP
D000368:Aged; D000704:Analysis of Variance; D000954:Antigens, Surface / Q000032:analysis; D020732:Cytogenetic Analysis; D004305:Dose-Response Relationship, Drug; D012739:Gonadal Steroid Hormones / Q000097:blood; D006801:Humans; D007124:Immunoenzyme Techniques; D008214:Lymphocytes / Q000187:drug effects; D008297:Male; D009929:Organ Size; D010936:Plant Extracts / Q000494:pharmacology / Q000627:therapeutic use*; D011467:Prostate / Q000187:drug effects / Q000473:pathology*; D011470:Prostatic Hyperplasia / Q000188:drug therapy* / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D011788:Quality of Life
D000954:Antigens, Surface; D012739:Gonadal Steroid Hormones; C401831:PM 40; D010936:Plant Extracts